about
An approach to increased polyplex gene delivery by peptides selected from a phage display library.Higher and lower active circulating VWF levels: different facets of von Willebrand disease.Bioconjugation in pharmaceutical chemistry.Detection of a fluorescent-labeled avidin-nucleic acid nanoassembly by confocal laser endomicroscopy in the microvasculature of chronically inflamed intestinal mucosa.A New ELISA Using the ANANAS Technology Showing High Sensitivity to diagnose the Bovine Rhinotracheitis from Individual Sera to Pooled Milk.In vivo fate of avidin-nucleic acid nanoassemblies as multifunctional diagnostic tools.Discrimination between ulcerative colitis and Crohn's disease using phage display identified peptides and virus-mimicking synthetic nanoparticles.Optimized avidin nucleic acid nanoassemblies by a tailored PEGylation strategy and their application as molecular amplifiers in detection.The effect of Na(2)CO(3), NaF and NH(4)OH on the stability and release behavior of sol-gel derived silica xerogels embedded with bioactive compounds.Selective alkylation and acylation of alpha and epsilon amino groups with PEG in a somatostatin analogue: tailored chemistry for optimized bioconjugates.DNA condensation by high-affinity interaction with avidin.Effects of surfactant characteristics on drug availability from suppositories.Influence of synthesis and processing conditions on the release behavior and stability of sol-gel derived silica xerogels embedded with bioactive compounds.In vitro and in vivo evaluation of acellular diaphragmatic matrices seeded with muscle precursors cells and coated with VEGF silica gels to repair muscle defect of the diaphragm.Integrated architecture for the electrical detection of plasmonic resonances based on high electron mobility photo-transistors.A single-step photolithographic interface for cell-free gene expression and active biochips.Mesoporous silica sub-micron spheres as drug dissolution enhancers: Influence of drug and matrix chemistry on functionality and stability.fac-{Ru(CO)3}2+-core complexes and design of metal-based drugs. synthesis, structure, and reactivity of Ru-thiazole derivative with serum proteins and absorption-release studies with acryloyl and silica hydrogels as carriers in physiological media.C2362F mutation gives rise to an ADAMTS13-resistant von Willebrand factor.Improvement and extension of anti-EGFR targeting in breast cancer therapy by integration with the Avidin-Nucleic-Acid-Nano-AssembliesBisphosphonate complexation and calcium doping in silica xerogels as a combined strategy for local and controlled release of active platinum antitumor compoundsCovalent modification of mushroom tyrosinase with different amphiphic polymers for pharmaceutical and biocatalysis applicationsA labeling, detection, and purification system based on 4-hydroxyazobenzene-2-carboxylic acid: an extension of the avidin-biotin systemInfluence of processing conditions in the manufacture of O/W creams: I. Effect on dispersion grade and rheological characteristicsN-hydroxysuccinimide carbonates and carbamates are useful reactive reagents for coupling ligands to lysines on proteinsWet sol-gel derived silica for controlled release of proteinsCharacterization of multifunctional nanosystems based on the avidin-nucleic acid interaction as signal enhancers in immuno-detectionSynthesis and chromatography-free purification of PNA-PEO conjugates for the functionalisation of gold sensorsThe p.R1819_C1948delinsS mutation makes von Willebrand factor ADAMTS13-resistant and reduces its collagen-binding capacityDexamethasone Conjugation to Biodegradable Avidin-Nucleic-Acid-Nano-Assemblies Promotes Selective Liver Targeting and Improves Therapeutic Efficacy in an Autoimmune Hepatitis Murine Model
P50
Q30837176-AC9766D3-A71A-45B1-BF67-8E5A1992883EQ33426606-1B39C190-6BC9-4D5F-A247-A5B02E788FC9Q33746346-1DE7413A-EDB4-4A70-8CFD-F950E8E40D1FQ34960433-837706FB-5B95-4B50-B9DE-5C8A40CCC84BQ35892892-21AA438A-504F-4707-8FE8-F7E5A5148FFAQ39297207-BCDBFD6B-3D8D-4957-AA18-4CAAB76E9682Q40233855-D5DD4F19-DA92-44A9-A04F-7C4FCD77F431Q43043093-979A4A87-EAA9-46E5-84B3-FD4DD4E6D01BQ43207328-F2584858-B5AA-4C7E-9160-5BC4AF9D5874Q44222033-C7B7F192-E9E4-4979-B813-86B30F2BC769Q45073809-E575AA42-F33F-4D5B-9F8E-5132363EA2ABQ46498865-0750F5D2-ECA8-4E36-90E6-EAC4E26FF35AQ46567740-44D1D2B1-77C6-48EE-9709-B204401EF9B3Q47755646-60C83779-B83F-4CBB-84B5-48381458E4D6Q51136234-7A023F89-08F0-4547-ACB7-7D6E972BFFB5Q51581672-99786328-8525-4CE9-8B9B-C6BF734FCEC1Q51612328-B1FCC888-0BB4-471F-A7BD-7944CF9C8119Q51925884-ED9F9D2D-AF2B-493D-AE30-29E8C1B0B6BBQ53118446-44234C5E-21D3-49A3-9DAA-183A4034DAB1Q57030083-740AAED2-3B8B-4FF2-9AAC-38ED45E51CA1Q59172622-0F8E497A-8E75-4F5E-B2A6-796D998EE3E9Q71016183-A938A224-4E43-4773-A33E-62E260E577EDQ74240364-CC3C43B2-FDE1-40D4-B31A-CA2CA1E60713Q74273345-0273BD25-A180-40F9-ACF8-FD7EC70A0E3FQ74608335-5E3F47BD-9ACC-4443-A7D0-BFCCB6E11D6FQ79347441-D4958D8D-9D81-48CE-81BB-2BEC8F1858E1Q83636317-D4FB6164-110C-4769-B78D-BC8769AE50EEQ84971515-A16E3E20-C2F8-43BF-9BA3-2429E42649F5Q87170718-7955C794-A3F6-4356-8FB3-8AC0D6948D59Q92440235-4C7E10E2-19CE-42A2-92B5-0F3D58537BB3
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Margherita Morpurgo
@ast
Margherita Morpurgo
@en
Margherita Morpurgo
@es
Margherita Morpurgo
@nl
type
label
Margherita Morpurgo
@ast
Margherita Morpurgo
@en
Margherita Morpurgo
@es
Margherita Morpurgo
@nl
prefLabel
Margherita Morpurgo
@ast
Margherita Morpurgo
@en
Margherita Morpurgo
@es
Margherita Morpurgo
@nl
P106
P1153
56240629900
P31
P496
0000-0002-8767-1995